New drug JADE101 tested in healthy volunteers for first time
NCT ID NCT07525947
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 1 trial is testing a single dose of JADE101 in 40 healthy Japanese and Chinese adults to see if it is safe and how the body processes it. Researchers will monitor side effects and measure drug levels in the blood. This is an early step to gather basic safety information before testing the drug in people with a disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- JADE101
- What could go wrong
- This is a very early Phase 1 study in healthy people, so it cannot show whether JADE101 works for any disease. Many drugs fail in early testing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS (HV) are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Parexel Early Phase Clinical Unit (EPCU)
RECRUITINGGlendale, California, 91206, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pulsing light on the scalp boost brain performance?
- Can heavy water reveal how the liver makes fat?
- Which bridge exercise fires up your muscles most? a study investigates
- A new molecule enters human testing: can ZE66-0205 prove safe?
- Reading DNA clues: a blood test that could sniff out lung cancer
- Blood flow restriction may change how hamstrings use oxygen during exercise